Department of Pharmacology, University of Michigan, Ann Arbor, Michigan (R.F., B.G., K.D.L., S.L.S., A.B., M.E.G.); and Departments of Psychiatry (Y.C.) and Physiology and Biophysics (L.J.D.), Virginia Commonwealth University, Richmond, Virginia.
Department of Pharmacology, University of Michigan, Ann Arbor, Michigan (R.F., B.G., K.D.L., S.L.S., A.B., M.E.G.); and Departments of Psychiatry (Y.C.) and Physiology and Biophysics (L.J.D.), Virginia Commonwealth University, Richmond, Virginia
Mol Pharmacol. 2014 Jul;86(1):76-85. doi: 10.1124/mol.114.091926. Epub 2014 Apr 21.
The dopamine transporter (DAT) reversibly transports dopamine (DA) through a series of conformational transitions. Alanine (T62A) or aspartate (T62D) mutagenesis of Thr62 revealed T62D-human (h)DAT partitions in a predominately efflux-preferring conformation. Compared with wild-type (WT), T62D-hDAT exhibits reduced [(3)H]DA uptake and enhanced baseline DA efflux, whereas T62A-hDAT and WT-hDAT function in an influx-preferring conformation. We now interrogate the basis of the mutants' altered function with respect to membrane conductance and Na(+) sensitivity. The hDAT constructs were expressed in Xenopus oocytes to investigate if heightened membrane potential would explain the efflux characteristics of T62D-hDAT. In the absence of substrate, all constructs displayed identical resting membrane potentials. Substrate-induced inward currents were present in oocytes expressing WT- and T62A-hDAT but not T62D-hDAT, suggesting equal bidirectional ion flow through T62D-hDAT. Utilization of the fluorescent DAT substrate ASP(+) [4-(4-(dimethylamino)styryl)-N-methylpyridinium] revealed that T62D-hDAT accumulates substrate in human embryonic kidney (HEK)-293 cells when the substrate is not subject to efflux. Extracellular sodium (Na(+) e) replacement was used to evaluate sodium gradient requirements for DAT transport functions. The EC50 for Na(+) e stimulation of [(3)H]DA uptake was identical in all constructs expressed in HEK-293 cells. As expected, decreasing [Na(+)]e stimulated [(3)H]DA efflux in WT- and T62A-hDAT cells. Conversely, the elevated [(3)H]DA efflux in T62D-hDAT cells was independent of Na(+) e and commensurate with [(3)H]DA efflux attained in WT-hDAT cells, either by removal of Na(+) e or by application of amphetamine. We conclude that T62D-hDAT represents an efflux-willing, Na(+)-primed orientation-possibly representing an experimental model of the conformational impact of amphetamine exposure to hDAT.
多巴胺转运体(DAT)通过一系列构象转变可逆地转运多巴胺(DA)。Thr62 的丙氨酸(T62A)或天冬氨酸(T62D)突变揭示了 T62D-人(h)DAT 主要以外排优先构象分配。与野生型(WT)相比,T62D-hDAT 表现出减少的 [(3)H]DA 摄取和增强的基础 DA 外排,而 T62A-hDAT 和 WT-hDAT 则以入流优先构象发挥作用。我们现在用膜电导和 Na(+) 敏感性来探究突变体改变功能的基础。hDAT 构建体在非洲爪蟾卵母细胞中表达,以研究如果增加膜电位是否可以解释 T62D-hDAT 的外排特征。在没有底物的情况下,所有构建体均显示出相同的静息膜电位。在表达 WT 和 T62A-hDAT 的卵母细胞中存在底物诱导的内向电流,但在 T62D-hDAT 中不存在,表明 T62D-hDAT 中存在双向离子流。利用荧光 DAT 底物 ASP(+) [4-(4-(二甲基氨基)苯乙烯基)-N-甲基吡啶鎓] 表明,当底物不受外排影响时,T62D-hDAT 在人胚肾 (HEK)-293 细胞中积累底物。用胞外钠 (Na(+) e) 替换来评估 DAT 转运功能对钠梯度的要求。在 HEK-293 细胞中表达的所有构建体中,Na(+) e 对 [(3)H]DA 摄取的 EC50 相同。如预期的那样,降低 [Na(+)]e 刺激 WT 和 T62A-hDAT 细胞中的 [(3)H]DA 外排。相反,T62D-hDAT 细胞中升高的 [(3)H]DA 外排不依赖于 Na(+) e,与 WT-hDAT 细胞中的 [(3)H]DA 外排相当,无论是通过去除 Na(+) e 还是通过应用安非他命来实现。我们得出结论,T62D-hDAT 代表一种外排意愿、Na(+) 启动的取向-可能代表 hDAT 暴露于安非他命的构象影响的实验模型。